• About us
• Contact

Advertisement

Organisation › Details

mk2 Biotechnologies GmbH

mk2 Biotechnologies GmbH develops, produces and investigates peptides at highest purity and quality standards using a revolutionary scalable synthesis technology. This way mk2 Biotechnologies enables the production of authentic peptides, regardless of their physical or chemical properties, at large scales and low cost. The pre-seed activities were financed with grants by the Zeidler-Forschungs-Stiftung and the funding programs “FLÜGGE” and “EXIST-Forschungstransfer”. Several early-stage start-up awards including the Science4Life Venture Cup and the TUM IdeAward had recognized the unique approach and its high potential. *

 

	Start	2019-02-26 existent
	Person	Antonopoulos, Konstantinos (mk2 Biotechnologies 201902 CEO + Founder)
	Region	München (Munich)
	Country	Germany
	Street	9 Fallstr.
	City	81369 München
		Address record changed: 2021-08-03
Basic data	Employees	n. a.
		* Document for »About Section«: mk2 Biotechnologies GmbH. (7/29/21). "Press Release: mk2 Biotechnologies Receives a Multi-Million Sum in Seed Funding".
		Record changed: 2025-07-06

Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.